Statistics
Publications
15
Citations
1.8K
H-Index
13
Active since
2010
Stephanie Dodd is an author at Novartis (United States) specializing in pharmacology, pharmacy, and drug discovery.
Publications per year
2010–2023
15
15
The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1
Andrew A. Wylie, Joseph Schoepfer, Wolfgang Jahnke et al. · Nature · 2017 · 596 citations
Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist
Shifeng Pan, Xu Wu, Jiqing Jiang et al. · ACS Medicinal Chemistry Letters · 2010 · 328 citations
1–5 of 15